Madison, Wisconsin, biotechnology company Quincy Bioscience has received an undisclosed "capital infusion" from DaneVest Tech Fund I, an investment group in its hometown. Quincy will used the money to support national sales of its Prevagen Brain Cell Protection dietary supplements, which are supposed to combat memory loss.
Though it’s yet to even get its brain cell protection drug into Phase 1 trials, Quincy Bioscience is far from the typical young biotech on a shoestring budget. For one thing, there’s the Madison, Wisconsin company’s unusual technology. Quincy has patented the use of a jellyfish protein called aequorin to treat disorders that result from […]
Break down the silos. Take control of your provider data.
Mark Underwood made a tongue-in-cheek offer to federal officials Wednesday -- a free bottle of his company's brain-enhancing supplement to any member of Congress or the incoming administration who has forgotten to pay taxes within the last decade. The real goal behind the light-hearted pitch was serious: "To draw more attention to the memory disorders that exist in our country," Underwood said.